UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 328

Sortiert nach

Refined diagnostic criteria and classification of mast cell leukemia (MCL) and myelomastocytic leukemia (MML): a consensus proposal

Annals of oncology, 2014-09, Vol.25 (9), p.1691-1700

2014

Volltextzugriff (PDF)

KIT mutation analysis in mast cell neoplasms: recommendations of the European Competence Network on Mastocytosis

Leukemia, 2015-06, Vol.29 (6), p.1223-1232

2015

Volltextzugriff (PDF)

Predictors of clinical effectiveness of Hymenoptera venom immunotherapy

Clinical and experimental allergy, 2014-05, Vol.44 (5), p.736-746

2014

Volltextzugriff (PDF)

Minimal diagnostic criteria for myelodysplastic syndromes and separation from ICUS and IDUS: update and open questions

European journal of clinical investigation, 2009-07, Vol.39 (7), p.548-553

2009

Volltextzugriff (PDF)

Midostaurin: a magic bullet that blocks mast cell expansion and activation

Annals of oncology, 2017-10, Vol.28 (10), p.2367-2376

2017

Volltextzugriff (PDF)

Proposed diagnostic algorithm for patients with suspected mastocytosis: a proposal of the European Competence Network on Mastocytosis

Allergy (Copenhagen), 2014-10, Vol.69 (10), p.1267-1274

2014

Volltextzugriff (PDF)

Molecular profiling of myeloid progenitor cells in multi-mutated advanced systemic mastocytosis identifies KIT D816V as a distinct and late event

Leukemia, 2015-05, Vol.29 (5), p.1115-1122

2015

Volltextzugriff (PDF)

Splenomegaly, elevated alkaline phosphatase and mutations in the SRSF2/ASXL1/RUNX1 gene panel are strong adverse prognostic markers in patients with systemic mastocytosis

Leukemia, 2016-12, Vol.30 (12), p.2342-2350

2016

Volltextzugriff (PDF)

Validation of dermatopathological criteria to diagnose cutaneous lesions of mastocytosis: importance of KIT D816V mutation analysis

Journal of the European Academy of Dermatology and Venereology, 2022-08, Vol.36 (8), p.1367-1375

2022

Volltextzugriff (PDF)

Evaluation of Mast Cell Activation Syndromes: Impact of Pathology and Immunohistology

International archives of allergy and immunology, 2012-08, Vol.159 (1), p.1-5

2012

Volltextzugriff (PDF)

Proposed diagnostic criteria and classification of basophilic leukemias and related disorders

Leukemia, 2017-04, Vol.31 (4), p.788-797

2017

Volltextzugriff (PDF)

Standards and standardization in mastocytosis: Consensus Statements on Diagnostics, Treatment Recommendations and Response Criteria

European journal of clinical investigation, 2007-06, Vol.37 (6), p.435-453

2007

Volltextzugriff (PDF)

Identification of bromodomain-containing protein-4 as a novel marker and epigenetic target in mast cell leukemia

Leukemia, 2015-11, Vol.29 (11), p.2230-2237

2015

Volltextzugriff (PDF)

Differential diagnoses of systemic mastocytosis in routinely processed bone marrow biopsy specimens: a review

Pathobiology (Basel), 2010-01, Vol.77 (4), p.169

2010

Volltextzugriff (PDF)

Systemic mastocytosis with associated clonal haematological non-mast cell lineage diseases: a histopathological challenge

Journal of clinical pathology, 2004-06, Vol.57 (6), p.604-608

2004

Volltextzugriff (PDF)

Oncostatin M is a FIP1L1/PDGFRA‐dependent mediator of cytokine production in chronic eosinophilic leukemia

Allergy (Copenhagen), 2013-06, Vol.68 (6), p.713-723

2013

Volltextzugriff (PDF)

Additional mutations in SRSF2, ASXL1 and/or RUNX1 identify a high-risk group of patients with KIT D816V(+) advanced systemic mastocytosis

Leukemia, 2016-01, Vol.30 (1), p.136-143

2016

Volltextzugriff (PDF)

An unusual case of systemic mastocytosis associated with chronic lymphocytic leukaemia (SM-CLL)

Journal of clinical pathology, 2006-03, Vol.59 (3), p.264-268

2006

Volltextzugriff (PDF)

Diagnosis of mastocytosis: general histopathological aspects, morphological criteria, and immunohistochemical findings

Leukemia research, 2001-07, Vol.25 (7), p.543-551

2001

Volltextzugriff (PDF)

Systemic mastocytosis: progressive evolution of an occult disease into fatal mast cell leukemia: unique findings on an unusual hematological neoplasm

Medical oncology (Northwood, London, England), 2012-12, Vol.29 (5), p.3540-3546

2012

Volltextzugriff (PDF)

Systemic mastocytosis (SM) with associated BCR-ABL-positive myelogenous leukaemia (SM-AHNMD): evidence that mast cells do not belong to the leukaemic clone

Leukemia, 2011-06, Vol.25 (6), p.1050-1053

2011

Volltextzugriff (PDF)

On the way to targeted therapy of mast cell neoplasms: identification of molecular targets in neoplastic mast cells and evaluation of arising treatment concepts

European journal of clinical investigation, 2004-08, Vol.34 (s2), p.41-52

2004

Volltextzugriff (PDF)

The tryptase positive compact round cell infiltrate of the bone marrow (TROCI-BM): a novel histopathological finding requiring the application of lineage specific markers

Journal of clinical pathology, 2006-03, Vol.59 (3), p.298-302

2006

Volltextzugriff (PDF)

Systemic mastocytosis with associated myeloproliferative disease and precursor B lymphoblastic leukaemia with t(13;13)(q12;q22) involving FLT3

Journal of clinical pathology, 2008-08, Vol.61 (8), p.958-961

2008

Volltextzugriff (PDF)

Acute myeloid leukaemia with t(8;21) associated with “occult” mastocytosis. Report of an unusual case and review of the literature

Journal of clinical pathology, 2004-03, Vol.57 (3), p.324-328

2004

Volltextzugriff (PDF)

1 – 25 von 328

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(301)
Mit Volltextzugriff
(265)

Publikationsform

Sprache

Englisch
(278)
Deutsch
(49)
Japanisch
(26)
Spanisch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(235)
Science & Technology
(214)
Life Sciences & Biomedicine
(207)
Biological And Medical Sciences
(125)
Female
(112)
Medical Sciences
(110)
Male
(94)
Middle Aged
(83)
Pathology
(81)
Aged
(70)
Immunohistochemistry
(67)
Adult
(65)
Mastocytosis
(62)
Hematology
(54)
Oncology
(53)
Hematologic And Hematopoietic Diseases
(50)
Mast Cells - Pathology
(44)
Bone Marrow - Pathology
(40)
Mast Cells
(37)
Diagnosis, Differential
(36)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Refined diagnostic criteria and classification of mast cell leukemia (MCL) and myelomastocytic leukemia (MML): a consensus proposal

KIT mutation analysis in mast cell neoplasms: recommendations of the European Competence Network on Mastocytosis

Predictors of clinical effectiveness of Hymenoptera venom immunotherapy

Minimal diagnostic criteria for myelodysplastic syndromes and separation from ICUS and IDUS: update and open questions

Midostaurin: a magic bullet that blocks mast cell expansion and activation

Proposed diagnostic algorithm for patients with suspected mastocytosis: a proposal of the European Competence Network on Mastocytosis

Molecular profiling of myeloid progenitor cells in multi-mutated advanced systemic mastocytosis identifies KIT D816V as a distinct and late event

Splenomegaly, elevated alkaline phosphatase and mutations in the SRSF2/ASXL1/RUNX1 gene panel are strong adverse prognostic markers in patients with systemic mastocytosis

Validation of dermatopathological criteria to diagnose cutaneous lesions of mastocytosis: importance of KIT D816V mutation analysis

Evaluation of Mast Cell Activation Syndromes: Impact of Pathology and Immunohistology

Proposed diagnostic criteria and classification of basophilic leukemias and related disorders

Standards and standardization in mastocytosis: Consensus Statements on Diagnostics, Treatment Recommendations and Response Criteria

Identification of bromodomain-containing protein-4 as a novel marker and epigenetic target in mast cell leukemia

Differential diagnoses of systemic mastocytosis in routinely processed bone marrow biopsy specimens: a review

Systemic mastocytosis with associated clonal haematological non-mast cell lineage diseases: a histopathological challenge

Oncostatin M is a FIP1L1/PDGFRA‐dependent mediator of cytokine production in chronic eosinophilic leukemia

Additional mutations in SRSF2, ASXL1 and/or RUNX1 identify a high-risk group of patients with KIT D816V(+) advanced systemic mastocytosis

An unusual case of systemic mastocytosis associated with chronic lymphocytic leukaemia (SM-CLL)

Diagnosis of mastocytosis: general histopathological aspects, morphological criteria, and immunohistochemical findings

Systemic mastocytosis: progressive evolution of an occult disease into fatal mast cell leukemia: unique findings on an unusual hematological neoplasm

Systemic mastocytosis (SM) with associated BCR-ABL-positive myelogenous leukaemia (SM-AHNMD): evidence that mast cells do not belong to the leukaemic clone

On the way to targeted therapy of mast cell neoplasms: identification of molecular targets in neoplastic mast cells and evaluation of arising treatment concepts

The tryptase positive compact round cell infiltrate of the bone marrow (TROCI-BM): a novel histopathological finding requiring the application of lineage specific markers

Systemic mastocytosis with associated myeloproliferative disease and precursor B lymphoblastic leukaemia with t(13;13)(q12;q22) involving FLT3

Acute myeloid leukaemia with t(8;21) associated with “occult” mastocytosis. Report of an unusual case and review of the literature

Suchergebnisse filtern